The Power of Immune Cells: Understanding Mesothelioma’s Microenvironment

ByHolly Zink
The Power of Immune Cells: Understanding Mesothelioma's Microenvironment

In a recent study, researchers looked at how the body’s immune system responds to pleural mesothelioma, a type of lung cancer. The published their results in Pathobiology.

Researchers looked at samples from 60 pleural mesothelioma patients to study immune cells in the tumor area. They used markers to identify cell types and their impact on the disease. This study sheds light on using the immune system for improved treatments.

Immune Cells and Mesothelioma

Pleural mesothelioma is a type of cancer that affects the lining of the lungs. It is often caused by exposure to asbestos, a harmful mineral that was used in many industries in the past. Pleural mesothelioma is rare, but it can be very aggressive and difficult to treat.

A recent study looked at how the immune system responds to pleural mesothelioma. The immune system is the body’s defense against infections and diseases. It includes different types of cells. They can recognize and destroy harmful invaders, like bacteria, viruses, and cancer cells.

A Key to Better Treatment?

The study analyzed samples from 60 patients who were diagnosed with pleural mesothelioma. The researchers used a technique called immunohistochemistry. It studies markers on immune cells within tumors. The markers helped identify the type and job of immune cells. They were in the tumor microenvironment.

The researchers found that some immune cell markers were linked to a worse outcome. This was for patients with pleural mesothelioma. For example, high levels of CD3, CD4, CD8, CD163, and FOXP3+ immune cells were linked to worse outcomes. These cells regulate the immune response. Sometimes, they help cancer cells evade immune detection.

The study also looked at immune checkpoint receptors. These are proteins on immune cells that help regulate the immune response. They found that high levels of PD-1, CD27, and TIM-3 receptors on tumor-infiltrating lymphocytes were linked to worse survival. Immunotherapy drugs can target these receptors. They help the immune system fight cancer.

Researchers used hierarchical clustering analysis to group pleural mesothelioma samples by immune cell features. They found three groups. One had high immune cells, another had low, and a third had medium.

It was found that the group of pleural mesothelioma patients with high immune cell count had the worst survival rates. The study also identified specific proteins, such as CD47, CD70, and PD-L1, found in high levels in the tumor that can act as potential risk factors for these patients. These proteins have a role in regulating immune responses and can help cancer cells avoid detection by the immune system.

This study provides key insights. It shows the role of the immune system in pleural mesothelioma. It suggests that targeting certain immune cells and proteins in the tumor environment could be a promising approach. This could be a way to treat pleural mesothelioma in the future. More research is needed to confirm these findings and develop new treatments for this challenging disease.

Source:

Inaguma, Shingo, Chengbo Wang, Sunao Ito, Akane Ueki, Jerzy Lasota, Piotr Czapiewski, Renata Langfort, et al. “Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment.” Pathobiology: Journal of Immunopathology, Molecular and Cellular Biology, March 25, 2024. https://doi.org/10.1159/000538520.

 

 

Similar Posts

  • | |

    Macrophages May Hold Key to Fighting Mesothelioma

    ByAlex Strauss

    Researchers in Western Australia are investigating new ways of bolstering the immune system in an effort to fight cancers like mesothelioma. Like most types of cancer, malignant mesothelioma occurs primarily in people over 65. That is also the time in life when the immune system typically weakens. Researchers from Curtin University and the University of Western Australia say it is no coincidence that people become more susceptible to mesothelioma as their immunity wanes. In addition to age-related immune dysfunction, mesothelioma patients experience a further decline in immunity caused by the growing tumor itself. To better understand the connection between declining immunity and the onset of mesothelioma, the researchers are focusing on a particular type of immune system cell called a macrophage….

  • |

    Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

    ByAlex Strauss

    Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

  • |

    Asbestos Mesothelioma Risk Increased By Other Fibers

    ByAlex Strauss

    Asbestos is a fibrous mineral mined and used for decades in products ranging from insulation to cement, floor and ceiling tiles, adhesives, and friction products. It has been more than forty years since scientists confirmed the link between asbestos and malignant pleural mesothelioma, an aggressive cancer of the lining around the lungs and its use is now heavily regulated in the U.S. In recent years, another mineral called erionite, has also been implicated in mesothelioma cases. Now, a study conducted in France suggests that two other types of mineral particles used in industry may increase the risk of mesothelioma, particularly in people who are also exposed to asbestos. Researchers in Bordeaux, France compared the cases of 1,199 male industrial workers with…

  • |

    Localized Mesothelioma May Provide Longer Survival

    ByAlex Strauss

    Patients with a rare, localized form of pleural mesothelioma may have a better survival outlook than patients with the more common, diffuse variety. That conclusion comes from a team of thoracic surgeons at Cambridge University. Their goal was to determine what, if any, difference in survival could be expected between people with localized malignant mesothelioma (LMM) of the pleura and those with standard pleural mesothelioma. Most pleural mesothelioma patients have a type of cancer that tends to spread quickly in a sheet across the thin membrane that surrounds the lungs. While patients with LMM have identical mesothelioma cells, from a histological perspective, the growth pattern exhibited by these cells is distinctly different. Instead of spreading across the mesothelium, LMM presents as…

  • |

    Pleurodesis for Mesothelioma: Hard to Predict Success

    ByAlex Strauss

    Pleurodesis is a procedure often used to help relieve some of the symptoms of pleural mesothelioma, but there is still no way to predict how effective it will be in any individual patient. That is the conclusion of Australian researchers who performed a retrospective study on 390 mesothelioma patients enrolled in the Western Australian Mesothelioma Registry over 5 years. Just over 42% of those patients underwent pleurodesis. The procedure is used to reduce pleural effusions, the buildup of fluid between the layers of lung lining that can cause shortness of breath, cough, and chest pain. Pleurodesis for mesothelioma can be performed either surgically or chemically. Surgical pleurodesis involves mechanically irritating the parietal pleura, causing it to swell and adhere to the visceral…

  • |

    Implantable Catheter May Provide Mesothelioma Symptom Relief

    ByAlex Strauss

    An implantable catheter that allows cancer patients to drain their own excess lung fluid at home may improve quality of life for some mesothelioma patients. A company-sponsored study of the PleurX drainage system conducted in Germany and published in a German medical journal, suggests that the system may be especially beneficial for late-stage mesothelioma patients. Pleural mesothelioma is a malignancy of the pleural lining which surrounds the lungs. In its later stages, mesothelioma often results in pleural effusions, or a build-up of fluid in the space between the inner and outer parts of the pleura. The problem is also common in the later stages of lung cancer and breast cancer. Pleural effusions limit the ability of the lungs to expand, resulting in…